Semler Scientific (NASDAQ:SMLR) Announces Quarterly Earnings Results, Beats Estimates By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings data on Monday. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35, Zacks reports. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.93% and a net margin of 27.00%.

Semler Scientific Price Performance

Semler Scientific stock traded down $1.98 during trading hours on Thursday, hitting $38.13. The company had a trading volume of 188,426 shares, compared to its average volume of 192,246. The firm’s fifty day moving average is $26.37 and its 200-day moving average is $28.81. The firm has a market capitalization of $266.60 million, a P/E ratio of 19.57 and a beta of 0.92. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $53.38.

Insider Activity

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 30.20% of the stock is currently owned by corporate insiders.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.